This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Columbia University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2024
Title: Innovations of Mangaiarkarasi Asokan in HIV-1 Research
Introduction
Mangaiarkarasi Asokan is a notable inventor based in Rockville, MD, who has made significant contributions to the field of HIV research. He holds two patents that focus on neutralizing antibodies targeting HIV-1, showcasing his dedication to advancing medical science and improving treatment options for this global health issue.
Latest Patents
Asokan's latest patents include "10E8 neutralizing antibody variants that bind to the MPER region of HIV-1 GP41 and their use" and "Neutralizing antibodies to HIV-1 GP41 and their use." These patents disclose neutralizing antibodies that specifically bind to HIV-1 Env and their antigen-binding fragments. They also provide nucleic acids encoding these antibodies, vectors, and host cells. Furthermore, the patents outline methods for detecting HIV-1 using these antibodies and discuss their potential use in preventing and treating HIV-1 infections.
Career Highlights
Throughout his career, Asokan has worked with prestigious institutions such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Columbia University. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Asokan's notable coworkers include Young Do Kwon and Ivelin Georgiev. Their collaborative efforts have furthered the understanding of HIV-1 and the development of innovative treatments.
Conclusion
Mangaiarkarasi Asokan's work in the field of HIV research exemplifies the impact of innovative thinking and collaboration in science. His patents and career achievements highlight his commitment to improving health outcomes for individuals affected by HIV-1.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile